Clinical Trial

Experimental Tobacco Marketplace

Study Description

Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace

Electronic cigarettes (e-cigarettes) may be a safer alternative to conventional cigarettes and are available in a broad range of nicotine strengths. The overall goal of this project is to use an experimental analogue of the real-world tobacco marketplace to examine the effects of nicotine strength on e-cigarette consumption and the likelihood that current smokers will either switch to e-cigarettes (which may reduce harm) or use both products in combination (which may increase harm). Testing effects of e-cigarette nicotine strength under controlled conditions in a context that models the real world will facilitate evidence-based policies that have a net benefit to health.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - 3 mg/mL nicotine strength e-liquid

Availability of 3 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

Drug - 6 mg/mL nicotine strength e-liquid

Availability of 6 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

Drug - 12 mg/mL nicotine strength e-liquid

Availability of 12 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

Drug - 24 mg/mL nicotine strength e-liquid

Availability of 24 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace

Additional Information

Official Study Title

Effects of Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace on Tobacco Product Substitution

Clinical Trial ID

NCT03843047

ParticipAid ID

eZ6X2e